Amgen Inc Stock Ownership

Insider buying vs selling

Have Amgen Inc insiders been buying or selling?
Ronald D. SugarDirector2021-05-121,000$71.64
Ronald D. SugarDirector2021-05-121,000$250.59
Nancy A. GrygielSVP & CCO2021-05-112,500$162.60
Nancy A. GrygielSVP & CCO2021-05-112,500$252.51
R. Sanders WilliamsDirector2021-05-07250$251.78
Murdo GordonEVP Global Commercial Ops2021-05-03782$239.64
Linda H. LouieVP Finance & CAO2021-05-0317$239.64
Robert A. BradwayChairman CEO and President2021-05-032,850$239.64
David PiacquadSVP Business Development2021-05-03220$239.64
Jonathan P. GrahamEVP Gen. Counsel & Secy.2021-05-03548$239.64

1 of 6

AMGN insiders have sold more AMGN shares than they have bought in the last year

AMGN Shareholders

What type of owners hold Amgen Inc stock?
Blackrock Inc8.42%47,824,902$9.94BInstitution
Vanguard Group Inc8.30%47,110,872$9.79BInstitution
State Street Corp5.27%29,931,381$6.22BInstitution
Capital Research Global Investors5.16%29,310,617$6.09BInstitution
Primecap Management Co2.86%16,249,072$3.38BInstitution
Fmr LLC1.92%10,890,259$2.26BInstitution
Morgan Stanley1.77%10,040,932$2.09BInstitution
Geode Capital Management LLC1.76%9,994,174$2.08BInstitution
Northern Trust Corp1.33%7,579,004$1.58BInstitution
Charles Schwab Investment Management Inc1.28%7,242,037$1.51BInstitution

1 of 3

Amgen Stock Ownership FAQ

Who owns Amgen?

Amgen (NASDAQ: AMGN) is owned by 75.00% institutional shareholders, 0.92% Amgen insiders, and 24.09% retail investors. Blackrock Inc is the largest individual Amgen shareholder, owning 47.82M shares representing 8.42% of the company. Blackrock Inc's Amgen shares are currently valued at $9.94B.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.